Related Experiment Video

Updated: Aug 14, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Central nervous system tumors: what have we learned and where are we heading?

E R Laws

    CA: a Cancer Journal for Clinicians
    |December 5, 1998
    PubMed

    Insights

    Advances in molecular biology and clinical studies enhance brain tumor understanding and treatment. Future research focuses on novel therapies like gene and photodynamic therapy for improved patient outcomes.

    Area of Science:

    • Neuro-oncology
    • Molecular Biology
    • Clinical Research

    Background:

    • Studies in molecular biology, laboratory settings, and human trials have significantly advanced our understanding of brain tumor pathogenesis and behavior.
    • Progress in brain tumor treatment has been driven by technical innovations.

    Discussion:

    • Functional imaging, computer-guided stereotactic surgical devices, and radiosurgery represent key technical advancements improving current treatment modalities.
    • These technological improvements have enhanced the precision and efficacy of interventions for brain tumors.

    Key Insights:

    • Integrated research approaches, combining basic science with clinical application, are crucial for understanding complex diseases like brain tumors.
    • Technological innovation directly translates to improved patient care and treatment outcomes in neuro-oncology.

    Outlook:

    • Future research directions include novel chemotherapy delivery systems, gene therapy, boron neutron capture therapy, and photodynamic therapy.
    • These emerging therapeutic strategies hold promise for more targeted and effective brain tumor treatments.

    More Related Videos

    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

    Published on: November 28, 2015

    Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice05:39

    Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

    Published on: December 27, 2024

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.